American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$544M |
| 2 |
Apple
AAPL
|
+$224M |
| 3 |
Exxon Mobil
XOM
|
+$219M |
| 4 |
Meta Platforms (Facebook)
META
|
+$189M |
| 5 |
CRH
CRH
|
+$177M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$402M |
| 2 |
Colgate-Palmolive
CL
|
+$255M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$175M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.58% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Investar Holding Corp
ISTR
$223M
| $182K | ﹤0.01% |
11,821
| – | – |
|
|
EU
2677
enCore Energy
EU
$417M
| $179K | ﹤0.01% |
+45,487
| New | +$179K |
|
2678
Newell Brands
NWL
$2.48B
| $179K | ﹤0.01% |
27,864
+6,247
| +29% | +$40K |
|
2679
American Outdoor Brands
AOUT
$111M
| $177K | ﹤0.01% |
19,683
-155
| -0.8% | -$1.4K |
|
2680
Aldeyra Therapeutics
ALDX
$324M
| $177K | ﹤0.01% |
53,388
+36,528
| +217% | +$121K |
|
|
GOOD
2681
Gladstone Commercial Corp
GOOD
$608M
| $176K | ﹤0.01% |
12,337
+2,210
| +22% | +$31.5K |
|
|
AZUL
2682
DELISTED
Azul
AZUL
| $175K | ﹤0.01% |
43,839
| – | – |
|
2683
Alight
ALIT
$1.95B
| $174K | ﹤0.01% |
+23,582
| New | +$174K |
|
2684
908 Devices
MASS
$202M
| $174K | ﹤0.01% |
33,718
+5,295
| +19% | +$27.3K |
|
2685
eHealth
EHTH
$122M
| $173K | ﹤0.01% |
38,170
+5,120
| +15% | +$23.2K |
|
2686
Accuray
ARAY
$177M
| $173K | ﹤0.01% |
94,869
-6,350
| -6% | -$11.6K |
|
2687
Standard BioTools
LAB
$493M
| $172K | ﹤0.01% |
97,307
+70,924
| +269% | +$126K |
|
2688
Bausch Health
BHC
$2.68B
| $172K | ﹤0.01% |
24,636
| – | – |
|
|
PHX
2689
DELISTED
PHX Minerals
PHX
| $172K | ﹤0.01% |
52,622
| – | – |
|
2690
Blue Foundry Bancorp
BLFY
$198M
| $170K | ﹤0.01% |
18,699
-30
| -0.2% | -$272 |
|
|
TIGR
2691
UP Fintech Holding
TIGR
$2B
| $169K | ﹤0.01% |
40,135
| – | – |
|
2692
MeiraGTx Holdings
MGTX
$612M
| $168K | ﹤0.01% |
40,008
+11,907
| +42% | +$50.1K |
|
|
TEAD
2693
Teads Holding Co. Common Stock
TEAD
$163M
| $166K | ﹤0.01% |
+33,270
| New | +$166K |
|
2694
Revolve Group
RVLV
$1.59B
| $165K | ﹤0.01% |
+10,377
| New | +$165K |
|
2695
Adaptive Biotechnologies
ADPT
$1.92B
| $165K | ﹤0.01% |
45,562
+7,039
| +18% | +$25.5K |
|
2696
Lifecore Biomedical
LFCR
$281M
| $164K | ﹤0.01% |
31,982
-27,513
| -46% | -$141K |
|
|
NAPA
2697
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $164K | ﹤0.01% |
23,064
+8,335
| +57% | +$59.2K |
|
2698
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $163K | ﹤0.01% |
13,496
+1,921
| +17% | +$23.2K |
|
|
LOGC
2699
DELISTED
ContextLogic
LOGC
| $162K | ﹤0.01% |
28,429
+4,578
| +19% | +$26.1K |
|
2700
Trevi Therapeutics
TRVI
$1B
| $161K | ﹤0.01% |
54,108
+7,902
| +17% | +$23.5K |
|